Baird raised the firm’s price target on Alignment Healthcare (ALHC) to $22 from $17 and keeps an Outperform rating on the shares. The firm sees minimal incremental buyers of stocks in the managed care and healthcare facilities group until the policy overhang clears. Baird does not not expect guidance raises as it believes companies will maintain 2025 “conservatism and cushion” given potential Part D and macro headwinds that may evolve later this year.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALHC:
- Morning Movers: Stock futures rebound following days of dips
- Alignment Healthcare price target raised to $23 from $18 at Stifel
- Alignment Healthcare, Sutter Health renew long-term, strategic collaboration
- Alignment Healthcare management to meet with Stephens
- Alignment Healthcare price target raised to $18.50 from $15.50 at BofA
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue